A large prospective study tracking nearly 4,000 infants found no evidence that acetaminophen or ibuprofen increases the risk of eczema or bronchiolitis, challenging decades-old clinical concerns about these common fever reducers in babies.
The research followed children from birth and monitored their health outcomes alongside medication exposure. Neither pain reliever produced serious adverse effects during the infancy period studied. The findings contradict long-standing pediatric caution about ibuprofen in particular, which many clinicians have avoided prescribing to very young children due to theoretical risks.
The study represents one of the largest prospective investigations into safety profiles of these over-the-counter drugs in early childhood. Researchers are continuing to follow participants through age six to assess whether long-term exposure patterns affect immune-related conditions or other health outcomes that might emerge later.
The work addresses a practical gap in pediatric medicine. Parents and doctors have relied on limited evidence when choosing between acetaminophen and ibuprofen for fever management in babies. Hospital guidelines often recommend acetaminophen as first-line treatment in infants under three months, partly due to historical concerns rather than robust safety data comparing the two drugs directly.
These findings may shift clinical practice if confirmed by additional research. They suggest that ibuprofen could be considered a viable option alongside acetaminophen in infants older than several months, potentially offering more choices for fever management. The medicines work through different mechanisms, and some clinical situations favor one over the other based on efficacy rather than safety alone.
Important limitations remain. The study captures infancy through roughly one year of age; longer-term effects beyond age six remain unknown. Additionally, the research focused on eczema and bronchiolitis specifically. Other potential health outcomes require separate investigation. The sample composition and participant demographics may also affect generalizability to all infant populations.
Researchers plan